ScoreWhy is Zydus Lifesciences Ltd ?
1
High Management Efficiency with a high ROE of 19.00%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Healthy long term growth as Operating profit has grown by an annual rate 22.23%
4
The company has declared Positive results for the last 7 consecutive quarters
- ROCE(HY) Highest at 26.03%
- PBT LESS OI(Q) At Rs 1,126.90 cr has Grown at 30.13%
- PAT(Q) At Rs 1,023.75 cr has Grown at 32.5%
5
Stock is technically in a Bearish range
- The technical trend has deteriorated from Mildly Bearish on 27-Mar-25 and has generated -2.68% returns since then
- Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
6
With ROE of 19.6, it has a Attractive valuation with a 3.9 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -12.48%, its profits have risen by 33.2% ; the PEG ratio of the company is 0.6
7
Majority shareholders : Promoters
8
Underperformed the market in the last 1 year
- Even though the market (BSE 500) generated negative returns of -0.91% in the last 1 year, its fall in the stock was much higher with a return of -12.48%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Zydus Lifesci. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Drugs should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Zydus Lifesci. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Zydus Lifesci.
-12.58%
-0.45
27.80%
SENSEX
0.45%
0.03
14.48%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.66%
EBIT Growth (5y)
22.23%
EBIT to Interest (avg)
31.35
Debt to EBITDA (avg)
0.98
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.86
Tax Ratio
22.20%
Dividend Payout Ratio
7.82%
Pledged Shares
0
Institutional Holding
18.18%
ROCE (avg)
18.02%
ROE (avg)
19.00%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
19
Industry P/E
33
Price to Book Value
3.89
EV to EBIT
14.56
EV to EBITDA
12.60
EV to Capital Employed
4.24
EV to Sales
3.72
PEG Ratio
0.55
Dividend Yield
0.36%
ROCE (Latest)
27.81%
ROE (Latest)
19.63%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
ROCE(HY)
Highest at 26.03%
PBT LESS OI(Q)
At Rs 1,126.90 cr has Grown at 30.13%
PAT(Q)
At Rs 1,023.75 cr has Grown at 32.5%
-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Zydus Lifesci.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 1,126.90 cr has Grown at 30.13%
Year on Year (YoY)MOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 1,023.75 cr has Grown at 32.5%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
